Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is capitalizing on the continued corporate push for financially positive decentralized energy generation. “CIPI recently announced the successful commissioning of a major solar project located in American Tire Distributors’ (‘ATD’) Huntersville, North Carolina-based headquarters. This follows the successful…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, will be represented at the upcoming BIO CEO & Investor Conference. The conference is scheduled for Feb. 26–27, 2024, in New York City. According to the company, CFO Ryan Confer will present at the two-day event. His…
Clene (NASDAQ: CLNN) CEO Rob Etherington was the featured guest on a recent Proactive interview. According to an announcement, Etherington joined Proactive host Steve Darling to discuss recent news the company has released regarding results from its long-term, open-label extension (“LTE”) of the VISIONARY-MS trial. Clene is a late clinical-stage biopharmaceutical company focused on improving…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting “great strides” with the production and deliveries of its Class 1 and Class 3 commercial EVs. In addition, the company is reporting that its subsidiary, Mullen Advanced Energy LLC, “), is moving forward with the installation of its battery-pack production line at its…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has enrolled and dosed the first patient in the phase 2a expansion portion of its Acclaim-1 clinical study of Reqorsa(R) therapy (quaratusugene ozeplasmid). The study combines Genprex’s proprietary lead product candidate with AstraZeneca’s Tagrisso(R) to treat patients with late-stage…
NextPlat (NASDAQ: NXPL, NXPLW), a global e-Commerce provider, is preparing for the launch of its exclusive OPKO Health-branded storefront on Alibaba Group Holding Limited’s (“Alibaba”)(NYSE: BABA) Tmall Global in China. The move follows the company’s receipt of the initial set of approvals required to operate the store in the country. “We are pleased to reach…
Clene’s (NASDAQ: CLNN) lead drug candidate CNM-Au8 was the subject of two Phase 2a clinical trials, REPAIR-PD and REPAIR-MS, which evaluated the effects of CNM-Au8 on brain energy metabolite levels in participants with diagnoses of idiopathic Parkinson’s Disease (“PD”) and relapsing Multiple Sclerosis (“MS”), respectively. The REPAIR-PD and REPAIR-MS Phase 2 trials expanded the documented…
Turbo Energy (NASDAQ: TURB) is a designer, developer and manufacturer of photovoltaic energy generation, management and storage equipment. The company recently announced it had begun marketing its revolutionary “GoSolar” household solar energy system in partnership with Solar360, the energy division of Movistar – Latin America’s largest telecommunication company and one of the world’s 500 most…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it continues to capitalize on its first-mover advantage in the U.S. market with production and deliveries of its Class 1 EV cargo vans and Class 3 EV trucks. Mullen began Class 3 vehicle production in August 2023 and Class 1 production in…
Vision Marine Technologies Inc. (NASDAQ: VMAR) is a global leader and innovator within the electric recreational boating industry. The company is pioneering clean-energy transition on the water, selling 100% electric boats, outboard motors and technology in the marine industry. “Vision Marine Technologies is certainly part of this tide of green-energy transformation. In the last several…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received a vehicle order from Grupo Cavel for the sale of EVs its Electric Motors dealerships located in the Dominican Republic and Caribbean. The order was for 20 CAMPUS EV cargo vans. According to the announcement, Grupo Cavel plans to order additional vehicles and…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has submitted its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”). The application covers HYPER-H23-1, the company’s upcoming planned U.S. phase 1b hypertension clinical trial of DehydraTECH-CBD. According to the announcement, the company had a successful pre-IND meeting…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced the pricing of its public offering. According to the announcement, the “reasonable best efforts” public offering involves participation from healthcare-focused institutional investors and certain officers and directors of…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has reached a commercial electric-vehicle milestone: its all-electric Class 3 low cab forward chassis truck has received certification from the California Air Resources Board (“CARB”), which means the vehicle meets specific emissions standards in compliance with CARB regulations. The certification means the vehicle qualifies for important state…
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), a leading exploration and mine development company, is reporting that an expanded induced polarization/resistivity (“IP/Res”) survey now covers most of the Iska Iska Project, which is located in southwestern Bolivia. According to the announcement, the survey includes east-west lines that have been completed every 200 meters across…
Astrotech (NASDAQ: ASTC ), an instrumentation company focused on commercializing its proprietary ATi Mass Spectrometer Technology(TM) that is now used in airports and agriculture applications throughout the world, continues to expand its technology into new markets. “Astrotech has announced the introduction of its newest Pro-Control-1000(TM) product line of instrumentation designed to improve chemical manufacturing efficiencies.…
PaxMedica (NASDAQ: PXMD) recently released an insightful video detailing the outcomes of its Phase 2 study on autism spectrum disorder (“ASD”), initially published in the Annals of General Psychiatry. “This pivotal video highlights the research led by Chief Medical Officer Dr. David Hough and a team of ASD experts, and the potential of low-dose suramin…
FingerMotion (NASDAQ: FNGR), a mobile services and data company, has announced that it will be participating at the Microcap Conference; the conference is scheduled for Jan. 30–Feb. 1, 2024, in Atlantic City, New Jersey. FingerMotion CEO Martin J. Shen will be presenting at the conference; his presentation is scheduled to begin at 12:30 p.m. ET on…
Renovaro BioSciences (NASDAQ: RENB), a biotechnology corporation focusing on cell, gene and immunotherapy, has announced the results of its special meeting of shareholders (“special meeting”) held at 12:00 p.m. ET on Jan. 25, 2024. According to the announcement, all matters put forward before the company’s shareholders for consideration and approval, as set out in Renovaro’s…
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products, is congratulating its colead scientific research collaborator Professor Dr. Dirk Görlich, who is this year’s Louis-Jeantet Prize recipient. A director at the Max Planck Institute for Multidisciplinary Sciences (“MPI-NAT”), Görlich and his colleague Dr. Matthias Dobbelstein, from the University Medical Center Göttingen (“UMG”),…